TrialBreast (Edinburgh, Scotland)2020

Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial.

Steven David et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.